Showing results (181-190 of 224) with videos related to
Sort By:
Pageof 23
Journal of the National Cancer Institute|July 21, 2026
Summary recommendations from the NCI clinical trials planning meeting (CTPM) on advanced cutaneous squamous cell carcinoma in immunosuppressed patientsShlomo A Koyfman, Julie E Bauman, Mehrdad Mohseni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2025
Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus-Initiated Oropharynx CancerBarbara Burtness, Yael Flamand, Harry Quon, et al.Head & Neck|November 27, 2023
Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancerAnastasios Maniakas, Andrew Sullivan, Mimi I Hu, et al.EMBO Molecular Medicine|July 26, 2023
ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancerChristopher W Schultz, Yang Zhang, Rajaa Elmeskini, et al.Science Translational Medicine|January 28, 2021
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapiesCamille Tlemsani, Nobuyuki Takahashi, Lorinc Pongor, et al.Oral Oncology|October 31, 2020
Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial designChristopher W Fleming, Matthew C Ward, Neil M Woody, et al.JCI Insight|March 30, 2017
Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancerJulie E Bauman, Umamaheswar Duvvuri, William E Gooding, et al.Thyroid : Official Journal of the American Thyroid Association|July 20, 2019
Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAF-Mutated Anaplastic Thyroid CarcinomaJennifer R Wang, Mark E Zafereo, Ramona Dadu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2020
Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial ResultsRenata Ferrarotto, Diana Bell, Maria L Rubin, et al.European Journal of Cancer (Oxford, England : 1990)|December 22, 2020
Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neckMoran Amit, Chuan Liu, Frederico-Omar Netto Gleber, et al.Pageof 23